Influence of PARP-1 polymorphisms in patients after traumatic brain injury

Journal of Neurotrauma

Volumn 27, Issue 3, 2010, Pages 465-471

  Sarnaik, Ajit A ^a,e   Conley, Yvette P ^b   Okonkwo, David O ^c   Barr, Taura L ^b,f   Fink, Ericka L ^a   Szabo, Csaba ^d   Kochanek, Patrick M ^a   Clark, Robert S B ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

^e CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^f NATIONAL INSTITUTE OF NURSING RESEARCH   (United States)

Author keywords

ADP ribosyltransferase; Poly(ADP ribose) polymerase; Poly ADP ribosylation; Traumatic brain injury

Indexed keywords

DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; POLY(ADENOSINE DIPHOSPHATE RIBOSE);

ADOLESCENT; ADULT; AGED; ARTICLE; CATALYSIS; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; GLASGOW COMA SCALE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TRAUMATIC BRAIN INJURY;

ADOLESCENT; ADULT; AGED; BRAIN CHEMISTRY; BRAIN INJURIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POLY(ADP-RIBOSE) POLYMERASES; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROMOTER REGIONS, GENETIC; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 77950607663     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2009.1171     Document Type: Article

References (30)

1. Ame, J.C., Spenlehauer, C., and de Murcia, G. (2004). The PARP superfamily. Bioessays 26, 882-893.
2. Ansari, M.A., Roberts, K.N., and Scheff, S.W. (2008). A time course of contusion-induced oxidative stress and synaptic proteins in cortex in a rat model of TBI. J. Neurotrauma 25, 513-526.
3. Clark, R.S., Vagni, V.A., Nathaniel, P.D., Jenkins, L.W., Dixon, C.E., and Szabo, C. (2007). Local administration of the poly (ADP-ribose) polymerase inhibitor INO-1001 prevents NAD(+) depletion and improves water maze performance after traumatic brain injury in mice. J. Neurotrauma 24, 1399-1405.
4. Deng, Y., Thompson, B.M., Gao, X., and Hall, E.D. (2007). Temporal relationship of peroxynitrite-induced oxidative damage, calpain-mediated cytoskeletal degradation and neurodegeneration after traumatic brain injury. Exp. Neurol. 205, 154-165.
5. Diaz-Arrastia, R., and Baxter, V.K. (2006). Genetic factors in outcome after traumatic brain injury: what the human genome project can teach us about brain trauma. J. Head Trauma Rehabil. 21, 361-374.
6. Du, L., Bayir, H., Lai, Y., Zhang, X., Kochanek, P.M., Watkins, S.C., Graham, S.H., and Clark, R.S. (2004). Innate genderbased proclivity in response to cytotoxicity and programmed cell death pathway. J. Biol. Chem. 279, 38563-38570.
7. Du, L., Zhang, X., Han, Y.Y., Burke, N.A., Kochanek, P.M., Watkins, S.C., Graham, S.H., Carcillo, J.A., Szabo, C., and Clark, R.S. (2003). Intra-mitochondrial poly(ADP-ribosylation) contributes to NAD(+) depletion and cell death induced by oxidative stress. J. Biol. Chem. 278, 18426-18433.
8. Eliasson, M.J., Sampei, K., Mandir, A.S., Hurn, P.D., Traystman, R.J., Bao, J., Pieper, A., Wang, Z.Q., Dawson, T.M., Snyder, S.H., and Dawson, V.L. (1997). Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat. Med. 3, 1089-1095.
9. Endres, M., Scott, G.S., Salzman, A.L., Kun, E., Moskowitz, M.A., and Szabo, C. (1998). Protective effects of 5-iodo-6-amino-1,2- benzopyrone, an inhibitor of poly(ADP-ribose) synthetase against peroxynitrite-induced glial damage and stroke development. Eur. J. Pharmacol. 351, 377-382.
10. Fink, E.L., Lai, Y., Zhang, X., Janesko-Feldman, K., Adelson, P.D., Szabo, C., Berger, R.P., Sarnaik, A.A., Kochanek, P.M., and Clark, R.S. (2008). Quantification of poly(ADP-ribose)-modified proteins in cerebrospinal fluid from infants and children after traumatic brain injury. J. Cereb. Blood Flow Metab. 28, 1523-1529.
11. Frazer, K.A., Murray, S.S., Schork, N.J., and Topol, E.J. (2009). Human genetic variation and its contribution to complex traits. Nat. Rev. Genet. 10, 241-251.
12. Gandhi, S., and Wood, N.W. (2005). Molecular pathogenesis of Parkinson's disease. Hum. Mol. Genet. 14, Spec. No.2, 2749-2755.
13. Halmosi, R., Berente, Z., Osz, E., Toth, K., Literati-Nagy, P., and Sumegi, B. (2001). Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system. Mol. Pharmacol. 59, 1497-1505.
14. Heid, C.A., Stevens, J., Livak, K.J., and Williams, P.M. (1996). Real time quantitative PCR. Genome Res. 6, 986-994.
15. Hur, J.W., Sung, Y.K., Shin, H.D., Park, B.L., Cheong, H.S., and Bae, S.C. (2006). Poly(ADP-ribose) polymerase (PARP) polymorphisms associated with nephritis and arthritis in systemic lupus erythematosus. Rheumatology (Oxford) 45, 711-717.
16. Infante, J., Sanchez-Juan, P., Mateo, I., Rodriguez-Rodriguez, E., Sanchez-Quintana, C., Llorca, J., Fontalba, A., Terrazas, J., Oterino, A., Berciano, J., and Combarros, O. (2007). Poly (ADPribose) polymerase-1 (PARP-1) genetic variants are protective against Parkinson's disease. J. Neurol. Sci. 256, 68-70.
17. Ioannidis, J.P.A., Trikalinos, T.A., Ntzani, E.E., and Contopoulos-Ionnidis, D.G. (2003). Genetic associations in large versus small studies: an empirical assessment. Lancet 361, 567-571.
18. Lai, Y., Chen, Y., Watkins, S.C., Nathaniel, P.D., Guo, F., Kochanek, P.M., Jenkins, L.W., Szabo, C., and Clark, R.S. (2008). Identification of poly-ADP-ribosylated mitochondrial proteins after traumatic brain injury. J. Neurochem. 104, 1700-1711.
19. LaPlaca, M.C., Raghupathi, R., Verma, A., Pieper, A.A., Saatman, K.E., Snyder, S.H., and McIntosh, T.K. (1999). Temporal patterns of poly(ADP-ribose) polymerase activation in the cortex following experimental brain injury in the rat. J. Neurochem. 73, 205-213.
20. Mabley, J.G., Horvath, E.M., Murthy, K.G., Zsengeller, Z., Vaslin, A., Benko, R., Kollai, M., and Szabo, C. (2005). Gender differences in the endotoxin-induced inflammatory and vascular responses: potential role of poly(ADP-ribose) polymerase activation. J. Pharmacol. Exp. Ther. 315, 812-820.
21. Myburgh, J.A., Cooper, D.J., Finfer, S.R., Venkatesh, B., Jones, D., Higgins, A., Bishop, N., and Higlett, T. (2008). Epidemiology and 12-month outcomes from traumatic brain injury in Australia and New Zealand. J. Trauma. 64, 854-862.
22. Nagayama, T., Simon, R.P., Chen, D., Henshall, D.C., Pei, W., Stetler, R.A., and Chen, J. (2000). Activation of poly(ADPribose) polymerase in the rat hippocampus may contribute to cellular recovery following sublethal transient global ischemia. J. Neurochem. 74, 1636-1645.
23. Satchell, M.A., Zhang, X., Kochanek, P.M., Dixon, C.E., Jenkins, L.W., Melick, J., Szabo, C., and Clark, R.S. (2003). A dual role for poly-ADP-ribosylation in spatial memory acquisition after traumatic brain injury in mice involving NAD(+) depletion and ribosylation of 14-3-3gamma. J. Neurochem. 85, 697-708.
24. Tao, Z., Gao, P., Hoffman, D.W., and Liu, H.W. (2008). Domain C of human poly(ADP-ribose) polymerase-1 is important for enzyme activity and contains a novel zinc-ribbon motif. Biochemistry 47, 5804-5813.
25. Thurman, D.J., Alverson, C., Dunn, K.A., Guerrero, J., and Sniezek, J.E. (1999). Traumatic brain injury in the United States: A public health perspective. J. Head Trauma Rehabil. 14, 602-615.
26. Ueda, K., and Hayaishi, O. (1985). ADP-ribosylation. Annu. Rev. Biochem. 54, 73-100.
27. Virag, L., and Szabo, C. (2002). The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol. Rev. 54, 375-429.
28. Wang, X.G., Wang, Z.Q., Tong, W.M., and Shen, Y. (2007). PARP1 Val762Ala polymorphism reduces enzymatic activity. Biochem. Biophys. Res. Commun. 354, 122-126.
29. Whalen, M.J., Clark, R.S., Dixon, C.E., Robichaud, P., Marion, D.W., Vagni, V., Graham, S.H., Virag, L., Hasko, G., Stachlewitz, R., Szabo, C., and Kochanek, P.M. (1999). Reduction of cognitive and motor deficits after traumatic brain injury in mice deficient in poly(ADP-ribose) polymerase. J. Cereb. Blood Flow Metab. 19, 835-842.
30. Yu, S.W., Wang, H., Poitras, M.F., Coombs, C., Bowers, W.J., Federoff, H.J., Poirier, G.G., Dawson, T.M., and Dawson, V.L. (2002). Mediation of poly(ADP-ribose) polymerase-1- dependent cell death by apoptosis-inducing factor. Science 297, 259-263.